DAWN
Price
$13.76
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
47 days until earnings call
SWTX
Price
$35.42
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
43 days until earnings call
Ad is loading...

DAWN vs SWTX

Header iconDAWN vs SWTX Comparison
Open Charts DAWN vs SWTXBanner chart's image
Day One Biopharmaceuticals
Price$13.76
Change-$0.00 (-0.00%)
Volume$541.27K
CapitalizationN/A
SpringWorks Therapeutics
Price$35.42
Change-$0.00 (-0.00%)
Volume$642.78K
CapitalizationN/A
View a ticker or compare two or three
DAWN vs SWTX Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DAWN vs. SWTX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a StrongSell and SWTX is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (DAWN: $13.76 vs. SWTX: $35.42)
Brand notoriety: DAWN and SWTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 57% vs. SWTX: 74%
Market capitalization -- DAWN: $1.35B vs. SWTX: $2.63B
DAWN [@Biotechnology] is valued at $1.35B. SWTX’s [@Biotechnology] market capitalization is $2.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileSWTX’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • SWTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DAWN and SWTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 3 TA indicator(s) are bullish while SWTX’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 3 bullish, 4 bearish.
  • SWTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SWTX is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а -4.04% price change this week, while SWTX (@Biotechnology) price change was -8.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 04, 2024.

SWTX is expected to report earnings on Oct 31, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWTX($2.63B) has a higher market cap than DAWN($1.35B). SWTX YTD gains are higher at: -2.959 vs. DAWN (-5.753). DAWN has higher annual earnings (EBITDA): -291.8M vs. SWTX (-318.71M). SWTX has more cash in the bank: 384M vs. DAWN (362M). DAWN has less debt than SWTX: DAWN (190K) vs SWTX (7.06M). SWTX has higher revenues than DAWN: SWTX (86.2M) vs DAWN (8.19M).
DAWNSWTXDAWN / SWTX
Capitalization1.35B2.63B51%
EBITDA-291.8M-318.71M92%
Gain YTD-5.753-2.959194%
P/E RatioN/AN/A-
Revenue8.19M86.2M10%
Total Cash362M384M94%
Total Debt190K7.06M3%
TECHNICAL ANALYSIS
Technical Analysis
DAWNSWTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SWTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LYRCX25.690.22
+0.86%
Lyrical US Value Equity C
PCSGX14.730.07
+0.48%
PACE Small/Medium Co Growth Equity P
MVCAX34.180.11
+0.32%
MFS Mid Cap Value A
MMLRX15.92N/A
N/A
MassMutual Select TRP Large Cap Blend I
VICAX21.25-0.15
-0.70%
USA Mutuals Vice A

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with NTLA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+0.95%
NTLA - DAWN
48%
Loosely correlated
+4.83%
BBIO - DAWN
47%
Loosely correlated
+2.06%
DNLI - DAWN
47%
Loosely correlated
+1.15%
NRIX - DAWN
46%
Loosely correlated
-2.40%
INZY - DAWN
45%
Loosely correlated
-2.67%
More